Goldman Sachs Group Inc Absci Corp Transaction History
Goldman Sachs Group Inc
- $605 Billion
- Q3 2024
A detailed history of Goldman Sachs Group Inc transactions in Absci Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 277,364 shares of ABSI stock, worth $743,335. This represents 0.0% of its overall portfolio holdings.
Number of Shares
277,364
Previous 645,589
57.04%
Holding current value
$743,335
Previous $1.99 Million
46.73%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding ABSI
# of Institutions
127Shares Held
59.1MCall Options Held
255KPut Options Held
93.6K-
Redmile Group, LLC San Francisco, CA8.25MShares$22.1 Million2.06% of portfolio
-
Fred Alger Management, LLC New York, NY7.57MShares$20.3 Million0.15% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.34MShares$17 Million0.23% of portfolio
-
Black Rock Inc. New York, NY5.34MShares$14.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.94MShares$13.2 Million0.0% of portfolio
About Absci Corp
- Ticker ABSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 92,843,504
- Market Cap $249M
- Description
- Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....